Company intelligence / Profile preview

Nostrum Pharmaceuticals

Somerset, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

Nostrum owns and manufactures various specialty and generic controlled-release oral drugs, with several FDA-approved ANDAs for CNS and infectious indications, many commercialized by partners such as Breckenridge and Strides

Therapeutic areas: CardiovascularImmunologyInfectious DiseasesNeurologyPsychiatry
Modalities: Small moleculeControlled-release drug deliveryProteinInhalation device
Industry: Biotech

Drug pipeline

1 asset

SMRX-11

Unknown

Partnerships

Sun Pharmaceutical Industries (asset/facility acquisition and product development partners)Breckenridge Pharmaceutical (product acquisition/sales; Nostrum retains manufacturing)Strides Pharma (sale of ANDAs for niche generic drugs)

Beyond the preview

Go deeper on Nostrum Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nostrum Pharmaceuticals.

Explore the full profile